GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Allarity Therapeutics Inc (FRA:C6D0) » Definitions » Market Cap

Allarity Therapeutics (FRA:C6D0) Market Cap : €7.46 Mil (As of Jun. 16, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Allarity Therapeutics Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Allarity Therapeutics's share price for the quarter that ended in Mar. 2024 was €1383.04. Allarity Therapeutics's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 0.34 Mil. Therefore, Allarity Therapeutics's market cap for the quarter that ended in Mar. 2024 was €474.06 Mil.

Allarity Therapeutics's quarterly market cap increased from Sep. 2023 (€289.44 Mil) to Dec. 2023 (€407.10 Mil) and increased from Dec. 2023 (€407.10 Mil) to Mar. 2024 (€474.06 Mil).

Allarity Therapeutics's annual market cap declined from Dec. 2021 (€2,244.21 Mil) to Dec. 2022 (€129.08 Mil) but then increased from Dec. 2022 (€129.08 Mil) to Dec. 2023 (€407.10 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Allarity Therapeutics's Enterprise Value for Today is €11.08 Mil.


Allarity Therapeutics Market Cap Historical Data

The historical data trend for Allarity Therapeutics's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allarity Therapeutics Market Cap Chart

Allarity Therapeutics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
- - 2,244.21 129.08 407.10

Allarity Therapeutics Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.05 34.82 289.44 407.10 474.06

Competitive Comparison of Allarity Therapeutics's Market Cap

For the Biotechnology subindustry, Allarity Therapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allarity Therapeutics's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Allarity Therapeutics's Market Cap distribution charts can be found below:

* The bar in red indicates where Allarity Therapeutics's Market Cap falls into.



Allarity Therapeutics Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Allarity Therapeutics's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=€1383.04*0.29435
=€407.10

Allarity Therapeutics's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=€1383.04*0.34277
=€474.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allarity Therapeutics  (FRA:C6D0) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Allarity Therapeutics Market Cap Related Terms

Thank you for viewing the detailed overview of Allarity Therapeutics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Allarity Therapeutics (FRA:C6D0) Business Description

Traded in Other Exchanges
Address
24 School Street, 2nd Floor, Boston, MA, USA
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improve clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.

Allarity Therapeutics (FRA:C6D0) Headlines

No Headlines